Abstract
This study was performed to determine the mechanisms for acquiring carbapenem resistance in six clinical isolates of Acinetobacter baumannii. All isolates showed similar SmaI-macrorestriction patterns with less than 3 band differences by PFGE. The isolates showed a high level resistance (>32 mg/L) to both imipenem and meropenem by Etest. Phe-Arg-β-naphthylamide lowered the MICs of carbapenems. Realtime PCR experiments showed that expression levels of the adeB gene in the six A. baumannii isolates were 10- to 40-times higher than those of imipenem-susceptible strains. Direct sequencing of PCR products showed that all isolates carried the blaOXA-23 gene, which was preceded by ISAba1. The blaOXA-23 probe hybridized with approximately 500-kb I-CeuI chromosomal fragments, but not with a plasmid. These findings suggest that overexpression of the AdeABC efflux pump as well as chromosome-borne OXA-23 may play a role in acquiring carbapenem resistance in our A. baumannii isolates.
Original language | English |
---|---|
Pages (from-to) | 43-48 |
Number of pages | 6 |
Journal | Annals of Clinical and Laboratory Science |
Volume | 40 |
Issue number | 1 |
Publication status | Published - 2010 Dec |
All Science Journal Classification (ASJC) codes
- Medicine(all)